Nikoletta Giannakou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nikoletta Giannakou has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Charikleia Triantopoulou
Department of Radiology, Konstantopouleio General Hospital, 14233 Athens, Greece
1 shared publication - Christos Dervenis
Department HPB Surgery, Metropolitan Hospital, Athens, Greece
1 shared publication - Costas Avgerinos
Liver Surgical Unit, First Department of Surgery, "Agia Olga" General Hospital, 3-5 Agias Olgas street, 14233 N. Ionia, Athens, Greece
1 shared publication - Spiros Delis
Department of Anatomy, Athens Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece
1 shared publication - Zisis Touloumis
Liver Surgical Unit, First Department of Surgery, "Agia Olga" General Hospital, 3-5 Agias Olgas street, 14233 N. Ionia, Athens, Greece
1 shared publication
Latest Publications
- Open Access
- 17 November 2008
- Published by Springer Nature in Cases Journal
- Vol. 1 (1) , 314
Primary hepatic carcinoid; a diagnostic dilemma: a case report
Introduction: Primary hepatic carcinoid tumours (PHCTs) are extremely rare neuroendocrine neoplasms. Only 58 cases have been reported in the literature and less than 10 cases were functional. Case presentation: We present a case of a 65 years old, Caucasian female with a large unresectable primary hepatic carcinoid tumor secreting 5-hydroxyindoleacetic acid (5-HIAA), presented with flushing and diarrhoea and treated with trans-catheter arterial embolization (TACE) and subsequent administration of lanreotide (long acting somatostatin analogue). Conclusion: The diagnosis of PHCTs is difficult due to their common radiologic characteristics with other liver lesions. Their diagnosis is based on the exclusion of other sites of disease and the histologic confirmation. Although the mainstay of treatment when is technically feasible is surgical resection with optimal 5-year survival and low recurrence rate, in cases of unresectable disease palliation with combination of TACE and administration of somatostatin analogues have good results in controlling the disease and the patients symptoms.
- 17 November 2008
- Published by Springer Nature in Cases Journal
- Vol. 1 (1) , 314
Open AccessPrimary hepatic carcinoid; a diagnostic dilemma: a case report
Introduction: Primary hepatic carcinoid tumours (PHCTs) are extremely rare neuroendocrine neoplasms. Only 58 cases have been reported in the literature and less than 10 cases were functional. Case presentation: We present a case of a 65 years old, Caucasian female with a large unresectable primary hepatic carcinoid tumor secreting 5-hydroxyindoleacetic acid (5-HIAA), presented with flushing and diarrhoea and treated with trans-catheter arterial embolization (TACE) and subsequent administration of lanreotide (long acting somatostatin analogue). Conclusion: The diagnosis of PHCTs is difficult due to their common radiologic characteristics with other liver lesions. Their diagnosis is based on the exclusion of other sites of disease and the histologic confirmation. Although the mainstay of treatment when is technically feasible is surgical resection with optimal 5-year survival and low recurrence rate, in cases of unresectable disease palliation with combination of TACE and administration of somatostatin analogues have good results in controlling the disease and the patients symptoms.